お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、HIV治療薬の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にHIV治療薬市場を分類しています。
本レポートでは世界のHIV治療薬市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：ViiV Healthcare、Gilead Sciences, Inc.、GlaxoSmithKline Plc、Merck Sharp & Dohme Corp.、Bristol-Myers Squibb Company、Janssen Pharmaceuticals, Inc.、Boehringer Ingelheim International GmbH、AbbVie Inc.、Genentech, Inc.、Mylan N.V.

レポートはHIV治療薬の主要生産者を調査し、主要地域や国の消費状況も提供します。HIV治療薬の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Integrase Inhibitors
    Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
    Combination HIV Medicines
    Others

用途別の市場セグメント：
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

本レポートの詳細内容
本レポートは、世界のHIV治療薬市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてHIV治療薬市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のHIV治療薬生産量、成長率、市場シェアを調査している。

二. 消費面では、HIV治療薬の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのHIV治療薬売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のHIV治療薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本HIV治療薬のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：HIV治療薬のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： HIV治療薬の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるHIV治療薬の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章HIV治療薬メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：HIV治療薬の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：HIV治療薬の主要メーカーの概要を提供し、製品の説明と仕様、HIV治療薬の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：HIV治療薬の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

HIV Therapy involves taking a combination of HIV medicines . HIV Therapy is recommended for everyone who has HIV. HIV Therapy cannot cure HIV, but HIV medicines help people with HIV live longer, healthier lives.
The global HIV Therapy market is projected to grow from US$ 3160 million in 2024 to US$ 3952.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.
The US & Canada market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for HIV Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of HIV Therapy include ViiV Healthcare, Gilead Sciences, Inc., GlaxoSmithKline Plc, Merck Sharp & Dohme Corp., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc. and Genentech, Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for HIV Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of HIV Therapy, also provides the sales of main regions and countries. Highlights of the upcoming market potential for HIV Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the HIV Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global HIV Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for HIV Therapy sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    ViiV Healthcare
    Gilead Sciences, Inc.
    GlaxoSmithKline Plc
    Merck Sharp & Dohme Corp.
    Bristol-Myers Squibb Company
    Janssen Pharmaceuticals, Inc.
    Boehringer Ingelheim International GmbH
    AbbVie Inc.
    Genentech, Inc.
    Mylan N.V.

Segment by Type
    Integrase Inhibitors
    Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
    Combination HIV Medicines
    Others

Segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies
    Others

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of HIV Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of HIV Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV Therapy sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global HIV Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Integrase Inhibitors
    Table 3. Major Manufacturers of Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
    Table 4. Major Manufacturers of Combination HIV Medicines
    Table 5. Major Manufacturers of Others
    Table 6. Global HIV Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global HIV Therapy Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 8. Global HIV Therapy Revenue by Region (2019-2024) & (US$ Million)
    Table 9. Global HIV Therapy Revenue by Region (2025-2030) & (US$ Million)
    Table 10. Global HIV Therapy Revenue Market Share by Region (2019-2024)
    Table 11. Global HIV Therapy Revenue Market Share by Region (2025-2030)
    Table 12. Global HIV Therapy Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 13. Global HIV Therapy Sales by Region (2019-2024) & (K Units)
    Table 14. Global HIV Therapy Sales by Region (2025-2030) & (K Units)
    Table 15. Global HIV Therapy Sales Market Share by Region (2019-2024)
    Table 16. Global HIV Therapy Sales Market Share by Region (2025-2030)
    Table 17. Global HIV Therapy Sales by Manufacturers (2019-2024) & (K Units)
    Table 18. Global HIV Therapy Sales Share by Manufacturers (2019-2024)
    Table 19. Global HIV Therapy Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 20. Global HIV Therapy Revenue Share by Manufacturers (2019-2024)
    Table 21. Global Key Players of HIV Therapy, Industry Ranking, 2022 VS 2023 VS 2024
    Table 22. HIV Therapy Price by Manufacturers 2019-2024 (US$/Unit)
    Table 23. Global HIV Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 24. Global HIV Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Therapy as of 2023)
    Table 25. Global Key Manufacturers of HIV Therapy, Manufacturing Base Distribution and Headquarters
    Table 26. Global Key Manufacturers of HIV Therapy, Product Offered and Application
    Table 27. Global Key Manufacturers of HIV Therapy, Date of Enter into This Industry
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 30. Global HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 31. Global HIV Therapy Sales Share by Type (2019-2024)
    Table 32. Global HIV Therapy Sales Share by Type (2025-2030)
    Table 33. Global HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 34. Global HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 35. Global HIV Therapy Revenue Share by Type (2019-2024)
    Table 36. Global HIV Therapy Revenue Share by Type (2025-2030)
    Table 37. HIV Therapy Price by Type (2019-2024) & (US$/Unit)
    Table 38. Global HIV Therapy Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 39. Global HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 40. Global HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 41. Global HIV Therapy Sales Share by Application (2019-2024)
    Table 42. Global HIV Therapy Sales Share by Application (2025-2030)
    Table 43. Global HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 44. Global HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 45. Global HIV Therapy Revenue Share by Application (2019-2024)
    Table 46. Global HIV Therapy Revenue Share by Application (2025-2030)
    Table 47. HIV Therapy Price by Application (2019-2024) & (US$/Unit)
    Table 48. Global HIV Therapy Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 49. US & Canada HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 50. US & Canada HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 51. US & Canada HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 52. US & Canada HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 53. US & Canada HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 54. US & Canada HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 55. US & Canada HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 56. US & Canada HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 57. US & Canada HIV Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 58. US & Canada HIV Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 59. US & Canada HIV Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 60. US & Canada HIV Therapy Sales by Country (2019-2024) & (K Units)
    Table 61. US & Canada HIV Therapy Sales by Country (2025-2030) & (K Units)
    Table 62. Europe HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 63. Europe HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 64. Europe HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 65. Europe HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 66. Europe HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 67. Europe HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 68. Europe HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 69. Europe HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 70. Europe HIV Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 71. Europe HIV Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 72. Europe HIV Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 73. Europe HIV Therapy Sales by Country (2019-2024) & (K Units)
    Table 74. Europe HIV Therapy Sales by Country (2025-2030) & (K Units)
    Table 75. China HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 76. China HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 77. China HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 78. China HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 79. China HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 80. China HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 81. China HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 82. China HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 83. Asia HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 84. Asia HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 85. Asia HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 86. Asia HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 87. Asia HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 88. Asia HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 89. Asia HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 90. Asia HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 91. Asia HIV Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 92. Asia HIV Therapy Revenue by Region (2019-2024) & (US$ Million)
    Table 93. Asia HIV Therapy Revenue by Region (2025-2030) & (US$ Million)
    Table 94. Asia HIV Therapy Sales by Region (2019-2024) & (K Units)
    Table 95. Asia HIV Therapy Sales by Region (2025-2030) & (K Units)
    Table 96. Middle East, Africa and Latin America HIV Therapy Sales by Type (2019-2024) & (K Units)
    Table 97. Middle East, Africa and Latin America HIV Therapy Sales by Type (2025-2030) & (K Units)
    Table 98. Middle East, Africa and Latin America HIV Therapy Revenue by Type (2019-2024) & (US$ Million)
    Table 99. Middle East, Africa and Latin America HIV Therapy Revenue by Type (2025-2030) & (US$ Million)
    Table 100. Middle East, Africa and Latin America HIV Therapy Sales by Application (2019-2024) & (K Units)
    Table 101. Middle East, Africa and Latin America HIV Therapy Sales by Application (2025-2030) & (K Units)
    Table 102. Middle East, Africa and Latin America HIV Therapy Revenue by Application (2019-2024) & (US$ Million)
    Table 103. Middle East, Africa and Latin America HIV Therapy Revenue by Application (2025-2030) & (US$ Million)
    Table 104. Middle East, Africa and Latin America HIV Therapy Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 105. Middle East, Africa and Latin America HIV Therapy Revenue by Country (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America HIV Therapy Revenue by Country (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America HIV Therapy Sales by Country (2019-2024) & (K Units)
    Table 108. Middle East, Africa and Latin America HIV Therapy Sales by Country (2025-2030) & (K Units)
    Table 109. ViiV Healthcare Company Information
    Table 110. ViiV Healthcare Description and Major Businesses
    Table 111. ViiV Healthcare HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 112. ViiV Healthcare HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 113. ViiV Healthcare Recent Developments
    Table 114. Gilead Sciences, Inc. Company Information
    Table 115. Gilead Sciences, Inc. Description and Major Businesses
    Table 116. Gilead Sciences, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 117. Gilead Sciences, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 118. Gilead Sciences, Inc. Recent Developments
    Table 119. GlaxoSmithKline Plc Company Information
    Table 120. GlaxoSmithKline Plc Description and Major Businesses
    Table 121. GlaxoSmithKline Plc HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 122. GlaxoSmithKline Plc HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 123. GlaxoSmithKline Plc Recent Developments
    Table 124. Merck Sharp & Dohme Corp. Company Information
    Table 125. Merck Sharp & Dohme Corp. Description and Major Businesses
    Table 126. Merck Sharp & Dohme Corp. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 127. Merck Sharp & Dohme Corp. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 128. Merck Sharp & Dohme Corp. Recent Developments
    Table 129. Bristol-Myers Squibb Company Company Information
    Table 130. Bristol-Myers Squibb Company Description and Major Businesses
    Table 131. Bristol-Myers Squibb Company HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 132. Bristol-Myers Squibb Company HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 133. Bristol-Myers Squibb Company Recent Developments
    Table 134. Janssen Pharmaceuticals, Inc. Company Information
    Table 135. Janssen Pharmaceuticals, Inc. Description and Major Businesses
    Table 136. Janssen Pharmaceuticals, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 137. Janssen Pharmaceuticals, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 138. Janssen Pharmaceuticals, Inc. Recent Developments
    Table 139. Boehringer Ingelheim International GmbH Company Information
    Table 140. Boehringer Ingelheim International GmbH Description and Major Businesses
    Table 141. Boehringer Ingelheim International GmbH HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 142. Boehringer Ingelheim International GmbH HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 143. Boehringer Ingelheim International GmbH Recent Developments
    Table 144. AbbVie Inc. Company Information
    Table 145. AbbVie Inc. Description and Major Businesses
    Table 146. AbbVie Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 147. AbbVie Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 148. AbbVie Inc. Recent Developments
    Table 149. Genentech, Inc. Company Information
    Table 150. Genentech, Inc. Description and Major Businesses
    Table 151. Genentech, Inc. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 152. Genentech, Inc. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 153. Genentech, Inc. Recent Developments
    Table 154. Mylan N.V. Company Information
    Table 155. Mylan N.V. Description and Major Businesses
    Table 156. Mylan N.V. HIV Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 157. Mylan N.V. HIV Therapy Product Model Numbers, Pictures, Descriptions and Specifications
    Table 158. Mylan N.V. Recent Developments
    Table 159. Key Raw Materials Lists
    Table 160. Raw Materials Key Suppliers Lists
    Table 161. HIV Therapy Distributors List
    Table 162. HIV Therapy Customers List
    Table 163. HIV Therapy Market Trends
    Table 164. HIV Therapy Market Drivers
    Table 165. HIV Therapy Market Challenges
    Table 166. HIV Therapy Market Restraints
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. HIV Therapy Product Picture
    Figure 2. Global HIV Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global HIV Therapy Market Share by Type in 2023 & 2030
    Figure 4. Integrase Inhibitors Product Picture
    Figure 5. Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Product Picture
    Figure 6. Combination HIV Medicines Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global HIV Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global HIV Therapy Market Share by Application in 2023 & 2030
    Figure 10. Hospital Pharmacies
    Figure 11. Retail Pharmacies
    Figure 12. Online Pharmacies
    Figure 13. Others
    Figure 14. HIV Therapy Report Years Considered
    Figure 15. Global HIV Therapy Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global HIV Therapy Revenue 2019-2030 (US$ Million)
    Figure 17. Global HIV Therapy Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 18. Global HIV Therapy Revenue Market Share by Region (2019-2030)
    Figure 19. Global HIV Therapy Sales 2019-2030 ((K Units)
    Figure 20. Global HIV Therapy Sales Market Share by Region (2019-2030)
    Figure 21. US & Canada HIV Therapy Sales YoY (2019-2030) & (K Units)
    Figure 22. US & Canada HIV Therapy Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Europe HIV Therapy Sales YoY (2019-2030) & (K Units)
    Figure 24. Europe HIV Therapy Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. China HIV Therapy Sales YoY (2019-2030) & (K Units)
    Figure 26. China HIV Therapy Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. Asia (excluding China) HIV Therapy Sales YoY (2019-2030) & (K Units)
    Figure 28. Asia (excluding China) HIV Therapy Revenue YoY (2019-2030) & (US$ Million)
    Figure 29. Middle East, Africa and Latin America HIV Therapy Sales YoY (2019-2030) & (K Units)
    Figure 30. Middle East, Africa and Latin America HIV Therapy Revenue YoY (2019-2030) & (US$ Million)
    Figure 31. The HIV Therapy Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 32. The Top 5 and 10 Largest Manufacturers of HIV Therapy in the World: Market Share by HIV Therapy Revenue in 2023
    Figure 33. Global HIV Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 34. Global HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 35. Global HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 36. Global HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 37. Global HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 39. US & Canada HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 40. US & Canada HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 41. US & Canada HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 42. US & Canada HIV Therapy Revenue Share by Country (2019-2030)
    Figure 43. US & Canada HIV Therapy Sales Share by Country (2019-2030)
    Figure 44. U.S. HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 45. Canada HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 46. Europe HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 47. Europe HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 48. Europe HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 49. Europe HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 50. Europe HIV Therapy Revenue Share by Country (2019-2030)
    Figure 51. Europe HIV Therapy Sales Share by Country (2019-2030)
    Figure 52. Germany HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 53. France HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 54. U.K. HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 55. Italy HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 56. Russia HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 57. China HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 58. China HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 59. China HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 60. China HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 61. Asia HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 62. Asia HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 63. Asia HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 64. Asia HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 65. Asia HIV Therapy Revenue Share by Region (2019-2030)
    Figure 66. Asia HIV Therapy Sales Share by Region (2019-2030)
    Figure 67. Japan HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 68. South Korea HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 69. China Taiwan HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 70. Southeast Asia HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 71. India HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 72. Middle East, Africa and Latin America HIV Therapy Sales Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America HIV Therapy Revenue Market Share by Type (2019-2030)
    Figure 74. Middle East, Africa and Latin America HIV Therapy Sales Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America HIV Therapy Revenue Market Share by Application (2019-2030)
    Figure 76. Middle East, Africa and Latin America HIV Therapy Revenue Share by Country (2019-2030)
    Figure 77. Middle East, Africa and Latin America HIV Therapy Sales Share by Country (2019-2030)
    Figure 78. Brazil HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 79. Mexico HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 80. Turkey HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 81. Israel HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 82. GCC Countries HIV Therapy Revenue (2019-2030) & (US$ Million)
    Figure 83. HIV Therapy Value Chain
    Figure 84. HIV Therapy Production Process
    Figure 85. Channels of Distribution
    Figure 86. Distributors Profiles
    Figure 87. Bottom-up and Top-down Approaches for This Report
    Figure 88. Data Triangulation
    Figure 89. Key Executives Interviewed